Initial ruling by judge sides with Hologic in ongoing patent dispute with Fujifilm

Fujifilm’s Aspire Cristalle breast imaging system violates four patents owned by Hologic, according to the initial ruling on July 26 of U.S. International Trade Commission Judge Clark Cheney.

The investigation is scheduled to be complete by Nov. 26, according to a report from Bloomberg Law. These findings are still subject to review, and the judge’s full opinion will be made public once both vendors have redacted confidential business information.

The dispute began in June 2017 when Hologic filed suit again Fujifilm Holdings over violation of the patents. The two vendors met with a mediator in February, but they were unable to resolve the conflict. Fujifilm filed a lawsuit against Hologic in March alleging Hologic’s Selenia Dimensions mammography systems infringe their own patents.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The ACR hopes these changes, including the addition of diagnostic performance feedback, will help reduce the number of patients with incidental nodules lost to follow-up each year.

And it can do so with almost 100% accuracy as a first reader, according to a new large-scale analysis.

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.